Research Grade Valziflocept (HF690016)

Name: Research Grade Valziflocept
Brand: abinScience
SKU: HF690016
Price: 220 USD
Availability: InStock

Price(USD): --

Spec:

Number:

Get quote

Overview

Catalog No.	HF690016
Description	Valziflocept (HF690016) is a research-grade recombinant antibody. Produced in mammalian cells with native-like glycosylation. Highlights ●Research Grade — For PK/PD studies, assay development, and ADA research. ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Species reactivity	Human
Applications	ELISA, Functional assay, Research in vivo
Clonality	Monoclonal
Isotype	Fc.Gamma.RIIb Receptor (Human Soluble Extracellular Fragment)
Expression system	Mammalian cells
Nature	Recombinant
Endotoxin level	< 10 EU/mg as determined by LAL method.
Purity	>95% as determined by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Form	Liquid
Storage buffer	0.01M PBS pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate Names	BAX1810, BAX-1810, FcγRIIb, HumansolubleFc-gammareceptorIIb, SHP652, SHP-652, SM-101
Background	Valziflocept (BAX1810; TAK-752) is a recombinant soluble human FcγRIIb receptor that targets Fc and FcγR. FcγRs bind and neutralize pathogenic IgG, thus forming a
Note	For research use only. Not suitable for clinical or therapeutic use.

Images

References

Datasheet

Download SDS PDF

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Mass

Concentration

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

V₁ (Stock Vol.)

Working Solution

C₂ (Working Conc.)

V₂ (Working Vol.)

Overview